Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Lidia Kovaleva"'
Autor:
Jorge Sierra, F. Hernandez, A. Julia, S. Loria, V. Sandoval, J. Ayguasanosa, M. Carretero, I. Alberca, Antonio Vidaller, Lidia Kovaleva
Publikováno v:
Transfusion medicine (Oxford, England). 19(5)
Idiopathic thrombocytopenic purpura (ITP) is an autoimmune disorder characterized by a low platelet count and bleeding, whose incidence is approximately 6.2 for each 100,000 adults per year. Intravenous immunoglobulins (IVIG) can be useful in patient
Autor:
James B. Bussel, Debasish F. Roychowdhury, Michael Arning, Bhabita Mayer, Abdulgabar Salama, Gregory Cheng, Tahir Shamsi, Bethan Psaila, Julian Jenkins, Nicole L. Stone, Drew Provan, Lidia Kovaleva
Publikováno v:
Lancet (London, England). 373(9664)
Eltrombopag is an oral, non-peptide, thrombopoietin-receptor agonist that stimulates thrombopoiesis, leading to increased platelet production. This study assessed the efficacy, safety, and tolerability of once daily eltrombopag 50 mg, and explored th
Autor:
Bethan Psaila, Balkis Meddeb, Drew Provan, Julian Jenkins, Habib Hassani, Gregory Cheng, Mansoor N. Saleh, Nicole L. Stone, Janusz Kloczko, Michael Arning, Bhabita Mayer, James B. Bussel, Lidia Kovaleva
Publikováno v:
The New England journal of medicine. 357(22)
The pathogenesis of chronic idiopathic thrombocytopenic purpura (ITP) involves antibody-mediated platelet destruction and reduced platelet production. Stimulation of platelet production may be an effective treatment for this disorder.We conducted a t
Autor:
Abdulgabar Salama, O. Zenker, Adrian C. Newland, Tadeusz Robak, Diane J. Nugent, Benjamin Brenner, Lidia Kovaleva, Louis M. Aledort
Publikováno v:
Hematology (Amsterdam, Netherlands). 12(4)
Objectives: This Phase III study examined the efficacy and safety of Rhophylac® (CSL Behring AG, Bern, Switzerland), a highly pure, liquid-stable anti-D preparation, in chronic immune thrombocytopenic purpura (ITP). Materials and methods: Ninety-eig
Autor:
Surendra Sirpal, Antonio Julià, Giraldo Kato, Lidia Kovaleva, Ali Khojasteh, Svetlana Loriya, Tammuella Singleton, Bruce Ritchie, Cameron K. Tebbi, Kapil Saxena, Jeffrey Letzer, Caroline Cromwell, Miguel A. Sanz, Jordi Navarro, Marcela Torres, Charles L. Sexauer, Craig M. Kessler, Virgilio Sandoval, Chieh-Lin Fu, Nehal S. Parikh, Maria A. Montanes
Publikováno v:
Blood. 116:4669-4669
Abstract 4669 Two similarly designed prospective, uncontrolled, open-label clinical trials were planned to assess the safety and efficacy of a new intravenous immunoglobulin (IVIG), IGIV3I 10% Grifols, in subjects with chronic immune thrombocytopenia
Autor:
Lidia Kovaleva
Publikováno v:
Angiosperm Pollen and Ovules ISBN: 9781461277330
InPetunia hybrida. the incompatibility reaction is mediated by both the haploid genome of the male gametophyte and the diploid genome of the female sporophyte tissues of pistil. Pollen carried to the stigma surface of the pistil produced the tubes th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9c1a650acdb513ec4f3537d8a86ebfb8
https://doi.org/10.1007/978-1-4612-2958-2_15
https://doi.org/10.1007/978-1-4612-2958-2_15
Autor:
James B. Bussel, Balkis Meddeb, Lidia Kovaleva, Mansoor N. Saleh, Manuel Aivado, Gregory Cheng, Bhabita Mayer, J. Lee Fraser
Publikováno v:
Blood. 110:566-566
Idiopathic thrombocytopenic purpura (ITP) is a disease caused by inadequate platelet production as well as increased platelet destruction. Eltrombopag is a first-in-class, oral, non-peptide platelet growth factor that increases platelet counts by int
Autor:
Yaroslava I. Vyhovska, Abdulgabar Salama, O. Zenker, Maria Gabriella Mazzucconi, Tadeusz Robak, Lidia Kovaleva, S. V. Davies
Publikováno v:
Blood. 110:1307-1307
Background Intravenous immunoglobulin (IVIG) is an accepted treatment for immune thrombocytopenic purpura (ITP). A new liquid 10% human IgG preparation stabilized with proline at a pH of 4.8 (trade name: Privigen) was recently developed. It can be st
Autor:
Lidia Kovaleva, Fernando Hernández, Svetlana Loria, Ignacio Alberca, Jorge Sierra, Antonio Julià, Antonio Vidaller, Virgilio Sandoval
Publikováno v:
Blood. 108:3956-3956
Intravenous immunoglobulin (IVIG) products are considered a useful treatment in patients with chronic idiopathic/immune thrombocytopenic purpura (ITP) to prevent bleeding or prior to surgery, when platelet counts have to be rapidly increased. IGIV3I
Autor:
Lidia Kovaleva, James B. Bussel, Andrew Provan, Bhabita Mayer, Nicole L. Stone, Julian Jenkins, Mansoor N. Saleh, Gregory Cheng
Publikováno v:
Blood. 108:475-475
Thrombocytopenia in ITP is due to both increased platelet clearance and inadequate platelet production. Bleeding episodes may occur as a result of the thrombocytopenia. Increasing the platelet count in patients with ITP may prevent or decrease bleedi